Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 202

Similar articles for PubMed (Select 15189341)

1.

A non-peptidyl neurotrophic small molecule for midbrain dopaminergic neurons.

Lin LF, Rubin LL, Xu M.

J Neurochem. 2004 Jun;89(6):1387-95.

PMID:
15189341
2.

Mammalian target of rapamycin complex 1 as an inducer of neurotrophic factors in dopaminergic neurons.

Kim SR.

Neural Regen Res. 2014 Dec 1;9(23):2036-7. doi: 10.4103/1673-5374.147923. No abstract available.

3.

The iron-binding protein lactoferrin protects vulnerable dopamine neurons from degeneration by preserving mitochondrial calcium homeostasis.

Rousseau E, Michel PP, Hirsch EC.

Mol Pharmacol. 2013 Dec;84(6):888-98. doi: 10.1124/mol.113.087965. Epub 2013 Sep 27.

4.

Vasonatrin peptide, a novel protector of dopaminergic neurons against the injuries induced by n-methyl-4-phenylpyridiniums.

Zhao HK, Chen BY, Chang R, Wang JB, Ni F, Yang L, Dong XC, Sun SH, Zhao G, Fang W, Ma QR, Wang XL, Yu J.

Peptides. 2013 Nov;49:117-22. doi: 10.1016/j.peptides.2013.09.005. Epub 2013 Sep 18.

PMID:
24055805
5.

New inputs to midbrain dopaminergic neurons: a new corticobasal ganglia model?

Trigo-Damas I.

Mov Disord. 2013 Feb;28(2):124. doi: 10.1002/mds.25322. No abstract available.

PMID:
23436629
6.

Using human pluripotent stem cell-derived dopaminergic neurons to evaluate candidate Parkinson's disease therapeutic agents in MPP+ and rotenone models.

Peng J, Liu Q, Rao MS, Zeng X.

J Biomol Screen. 2013 Jun;18(5):522-33. doi: 10.1177/1087057112474468. Epub 2013 Jan 30.

PMID:
23364514
7.

Establishment of a survival and toxic cellular model for Parkinson's disease from chicken mesencephalon.

Tolosa A, Zhou X, Spittau B, Krieglstein K.

Neurotox Res. 2013 Aug;24(2):119-29. doi: 10.1007/s12640-012-9367-y. Epub 2012 Dec 13.

8.

IL6 protects MN9D cells and midbrain dopaminergic neurons from MPP+-induced neurodegeneration.

Spittau B, Zhou X, Ming M, Krieglstein K.

Neuromolecular Med. 2012 Dec;14(4):317-27. doi: 10.1007/s12017-012-8189-7. Epub 2012 Jul 8.

PMID:
22772723
9.

Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.

Moldzio R, Pacher T, Krewenka C, Kranner B, Novak J, Duvigneau JC, Rausch WD.

Phytomedicine. 2012 Jun 15;19(8-9):819-24. doi: 10.1016/j.phymed.2012.04.002. Epub 2012 May 7.

PMID:
22571976
10.

Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector.

Addis RC, Hsu FC, Wright RL, Dichter MA, Coulter DA, Gearhart JD.

PLoS One. 2011;6(12):e28719. doi: 10.1371/journal.pone.0028719. Epub 2011 Dec 9.

11.

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage.

Chen SH, Wu HM, Ossola B, Schendzielorz N, Wilson BC, Chu CH, Chen SL, Wang Q, Zhang D, Qian L, Li X, Hong JS, Lu RB.

Br J Pharmacol. 2012 Jan;165(2):494-505. doi: 10.1111/j.1476-5381.2011.01575.x.

12.

Medium-throughput computer aided micro-island method to assay embryonic dopaminergic neuron cultures in vitro.

Planken A, Porokuokka LL, Hänninen AL, Tuominen RK, Andressoo JO.

J Neurosci Methods. 2010 Dec 15;194(1):122-31. doi: 10.1016/j.jneumeth.2010.10.005. Epub 2010 Oct 15.

PMID:
20951734
13.

Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone.

Nesti C, Pardini C, Barachini S, D'Alessandro D, Siciliano G, Murri L, Petrini M, Vaglini F.

Brain Res. 2011 Jan 7;1367:94-102. doi: 10.1016/j.brainres.2010.09.042. Epub 2010 Sep 18.

PMID:
20854799
14.

Protective effect of aripiprazole against glutamate cytotoxicity in dopaminergic neurons of rat mesencephalic cultures.

Matsuo T, Izumi Y, Kume T, Takada-Takatori Y, Sawada H, Akaike A.

Neurosci Lett. 2010 Sep 6;481(2):78-81. doi: 10.1016/j.neulet.2010.06.049. Epub 2010 Jun 23.

PMID:
20600606
15.

Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons.

Schmidt F, Le Douaron G, Champy P, Amar M, Séon-Méniel B, Raisman-Vozari R, Figadère B.

Bioorg Med Chem. 2010 Jul 15;18(14):5103-13. doi: 10.1016/j.bmc.2010.05.067. Epub 2010 Jun 2.

PMID:
20579892
16.

Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity.

Xing B, Xin T, Zhao L, Hunter RL, Chen Y, Bing G.

J Neuroimmunol. 2010 Aug 25;225(1-2):43-51. doi: 10.1016/j.jneuroim.2010.04.010. Epub 2010 May 14.

17.

KATP channel blockade protects midbrain dopamine neurons by repressing a glia-to-neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasis.

Toulorge D, Guerreiro S, Hirsch EC, Michel PP.

J Neurochem. 2010 Jul;114(2):553-64. doi: 10.1111/j.1471-4159.2010.06785.x. Epub 2010 Apr 29.

PMID:
20456014
18.

[Neurotoxicity effect of MPP+ on primary cultured mesencephalon neurons of SAMP8 mouse].

Liu J, Liu JQ, Liu L, Ma L, Wang YY, Ma QY, Wang MW.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2010 Feb;26(2):129-31. Chinese.

PMID:
20230671
19.

Minocycline protects dopaminergic neurons against long-term rotenone toxicity.

Radad K, Moldzio R, Rausch WD.

Can J Neurol Sci. 2010 Jan;37(1):81-5.

PMID:
20169778
20.

Enhanced dopaminergic differentiation of human neural stem cells by synergistic effect of Bcl-xL and reduced oxygen tension.

Krabbe C, Courtois E, Jensen P, Jørgensen JR, Zimmer J, Martínez-Serrano A, Meyer M.

J Neurochem. 2009 Sep;110(6):1908-20. doi: 10.1111/j.1471-4159.2009.06281.x. Epub 2009 Jul 17.

PMID:
19627448
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk